<DOC>
	<DOCNO>NCT00655369</DOCNO>
	<brief_summary>In Phase II trial subject nonrestorative sleep , PD 0200390 demonstrate positive treatment effect relative placebo primary endpoint , weekly version Restorative Sleep Questionnaire ( RSQ-W ) . In study , dose-response relationship vary dos PD 0200390 use Restorative Sleep Questionnaire ( RSQ-W ) , explore Nonrestorative Sleep subject .</brief_summary>
	<brief_title>A Double-blind , Parallel Group , Placebo-Controlled Outpatient Trial PD 00200390 Adults With Nonrestorative Sleep</brief_title>
	<detailed_description />
	<criteria>Awake unrestored unrefreshed , associated significant distress impairment social , occupational , important area function daytime , least 3 night past 3 month prior screen Selfreport wake sleep onset &lt; 45 min past 3 mo ; selfreport latency sleep onset &lt; 20 min past 3 mo PSG ( Polysomnography ) sleep criterion wake sleep onset &lt; 45 min ; Latency persistent sleep &lt; 20 min . MAP ( Multivariable Apnea Risk index ) index &gt; = 0.5 screen BMI = &gt; 32 kg/m2 History presence breathing related disorder PSG finding consistent periodic limb movement disorder , narcolepsy dyssomnia parasomnia include apneahypopnea index &gt; 10/hr ; period limb movement arousal index &gt; 10/hr .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>